NCT05455801 is a NA clinical trial of negative preassure wound therapy in Surgical Site Infection, sponsored by Hospital Universitario Central de Asturias.

Who is sponsoring NCT05455801?

NCT05455801 is sponsored by Hospital Universitario Central de Asturias.

What drugs are being tested in NCT05455801?

Interventions in NCT05455801: negative preassure wound therapy.

What condition does NCT05455801 study?

NCT05455801 studies Surgical Site Infection, Complication,Postoperative, Surgical Wound Infection, Surgical Complication.

Is NCT05455801 still recruiting?

NCT05455801 is currently completed. Last updated 13 July 2022.

Last reviewed 2022-07-13 · How we verify

NCT05455801

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study to Analyze the Surgical Site Infections in a Group of Patients Who Were Randomly Applied a Negative Pressure Therapy Dressing Versus Conventional Dressing

Completed NA Last updated 13 July 2022

What this trial tests

NA trial testing negative preassure wound therapy in Surgical Site Infection in 271 participants. Completed in 31 July 2021.

Timeline

1 March 2019

Primary endpoint
31 March 2021

31 July 2021

Quick facts

Lead sponsor	Hospital Universitario Central de Asturias
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	271
Start date	1 March 2019
Primary completion	31 March 2021
Estimated completion	31 July 2021
Sites	1 location across Spain

Drugs / interventions tested

negative preassure wound therapy

Conditions studied

Surgical Site Infection — all drugs for Surgical Site Infection →
Complication,Postoperative — all drugs for Complication,Postoperative →
Surgical Wound Infection — all drugs for Surgical Wound Infection →
Surgical Complication — all drugs for Surgical Complication →

Sponsor

Hospital Universitario Central de Asturias

Who can join

14 and older, any sex, with Surgical Site Infection or Complication,Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Surgical site complications generate a series of consequences that prolong hospital stay, increase interventions and procedures, and consequently considerably increase healthcare costs. Hence, the importance of studying measures to reduce these complications and the most feared of them is surgical site infection. The objective of the study is to analyze the complications of the surgical site in a group of participante with risk factors for developing them after undergone abdominal surgery in the period described.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Surgical Site Infection

Currently open trials in the same condition.

NCT07501897 — Investigating the Impact of Cold Atmospheric Plasma Treatment on Wound Healing at Cannulation Sites in Patients Followin · NA · recruiting
NCT07311395 — Local Subcutaneous Gentamicin for Prevention of Surgical Site Infection After Elective Cesarean Section · NA · recruiting
NCT06649890 — A Novel Surgical Irrigation Solution in Post-Mastectomy Reconstruction: Evaluating Xperience™ · NA · recruiting
NCT07005635 — The Effects of Different Time Reminder On Surgical Hand Scrubing · NA · active not recruiting
NCT07049614 — Comparative Study of Postoperative Surgical Site Infections in Diabetic and Non-Diabetic Patients · active not recruiting

Other Hospital Universitario Central de Asturias trials

Trials by the same sponsor.

NCT06201598 — Prospective, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Endovascular Treatment in Patient · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05455801 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Universitario Central de Asturias
Last refreshed: 13 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05455801.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing